Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
A narrative review synthesizing biological rationale, mechanisms, and current clinical evidence for bispecific antibodies across gastrointestinal cancers, offering expert perspective on therapeutic potential and future directions rather than reporting a primary clinical trial result.
A narrative review article summarizing mechanisms, resistance pathways, and emerging therapeutic strategies in GI cancer immunotherapy without presenting original clinical trial data or original research findings.